Edinoff, A. N., Alpaugh, E. S., Newgaard, O., Wajid, I., Klapper, R. J., Cornett, E. M., . . . Kaye, A. D. (2023). Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children. Life (2075-1729), 13(4), 889. https://doi.org/10.3390/life13040889
Chicago Style (17th ed.) CitationEdinoff, Amber N., Edward Sanders Alpaugh, Olivia Newgaard, Irza Wajid, Rachel J. Klapper, Elyse M. Cornett, Adam M. Kaye, Praneet Iyer, and Alan D. Kaye. "Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children." Life (2075-1729) 13, no. 4 (2023): 889. https://doi.org/10.3390/life13040889.
MLA (9th ed.) CitationEdinoff, Amber N., et al. "Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children." Life (2075-1729), vol. 13, no. 4, 2023, p. 889, https://doi.org/10.3390/life13040889.